Results 121 to 130 of about 23,157 (220)

Exploring the pharmacokinetic mechanisms that affect bictegravir exposure during pregnancy. [PDF]

J Antimicrob Chemother
van der Wekken-Pas L, Hidalgo-Tenorio C, Rockstroh JK, van Bremen K, Richel O, Molto J, Lambert JS, de Kanter C, Konopnicki D, Burger D, Colbers A.   +10 more
europepmc   +1 more source

Antiretroviral Treatment Switch Among Treatment-Experienced People with HIV. [PDF]

J Health Econ Outcomes Res
Chastek B, Mordi U, Christoph MJ, Le LB, Lim T, Majethia S, Trom C, Cohen J.   +7 more
europepmc   +1 more source

Timeliness of switching to second-line antiretroviral therapy following virologic failure in Dar es Salaam, Tanzania. [PDF]

BMC Res Notes
Thadeo MH, Bwire GM.
europepmc   +1 more source

Individualized immunotherapy for immune reconstitution-associated cortical encephalitis in an HIV-positive cryptococcal meningitis patient: a case report. [PDF]

Front Immunol
Wang W, Tang S, Yang J, Wen Y.
europepmc   +1 more source

Spatial and temporal variability and distribution of emerging contaminants in South African freshwater and wastewater. [PDF]

Sci Rep
Dikobe PI, Tekere M, Masindi V, Foteinis S.   +3 more
europepmc   +1 more source

Healthcare Resource Consumption and Related Costs of People Living with HIV and Antiviral Treatment: A Retrospective Observational Study in Italy. [PDF]

Diseases
Degli Esposti L, Mazzoni S, Cappuccilli M, Maggiolo F, Caputo SL, Nozza S, Taramasso L, Marra A, Pittorru M.   +8 more
europepmc   +1 more source

Virological outcomes with Bictegravir/Emtricitabine/Tenofovir alafenamide (B/F/TAF) in people previously treated with darunavir-based antiretroviral therapy. [PDF]

HIV Med
Sheridan R, Osei-Kuffour Ekert Y, Campbell L, Zuckerman M, Hawkins S, Childs K, Post FA.   +6 more
europepmc   +1 more source

Regional Variations of Rates and Determinants of Drug Resistance Mutations in People Failing First-line Therapy for HIV-1: A Substudy from the D2EFT Phase 3b/4 Clinical Trial. [PDF]

Clin Infect Dis
Obeng BM, Hutchinson J, Shaik A, Chetchotisakd P, Azwa I, Wulan WN, Kumarasamy N, Wolff M, Bruguera J, Losso M, Kaplan R, Diallo MS, Eriobu N, Musoro G, Kumalawati J, Badamasi A, Fitriah M, Mulya DP, Law M, Matthews G, Di Giallonardo F, Kelleher AD, Dolutegravir and Darunavir Evaluation in Adults Failing Therapy (D2EFT) Study Group.   +22 more
europepmc   +1 more source

Compound adsorption device in pathogen reduction technology removes multiple drugs from plasma components. [PDF]

Transfusion
Greenwall B, Reeder K, Anani WQ.
europepmc   +1 more source

Prolonged Paradoxical TB-IRIS: 2 Case Reports and a Review of the Literature. [PDF]

Open Forum Infect Dis
McClure M, Szumowski J, Chamie G, Louie J.   +3 more
europepmc   +1 more source